A-l Cheng
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.
Journal: ESMO open
Published: November 04, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 07, 2019
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.
Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2017
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.
Journal: Blood cancer journal
Published: February 13, 2014
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma.
Journal: Blood cancer journal
Published: February 06, 2014
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies.
Journal: British journal of cancer
Published: November 27, 2013
Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP.
Journal: Cell death & disease
Published: August 20, 2013
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance.
Journal: Blood cancer journal
Published: March 21, 2013
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.
Journal: Cell death & disease
Published: February 09, 2013
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
Journal: British journal of cancer
Published: December 22, 2012
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.
Journal: British journal of cancer
Published: October 13, 2012
Medulloblastoma in adults. Treatment outcome, relapse patterns, and prognostic factors.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: February 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026